iRadimed Corporation (IRMD): Price and Financial Metrics

iRadimed Corporation (IRMD): $35.54

-0.58 (-1.61%)

POWR Rating

Component Grades














  • Sentiment is the dimension where IRMD ranks best; there it ranks ahead of 99.85% of US stocks.
  • IRMD's strongest trending metric is Stability; it's been moving down over the last 179 days.
  • IRMD ranks lowest in Momentum; there it ranks in the 5th percentile.

IRMD Stock Summary

  • Price to trailing twelve month operating cash flow for IRMD is currently 52.65, higher than 90.46% of US stocks with positive operating cash flow.
  • IRMD's price/sales ratio is 14.18; that's higher than the P/S ratio of 89.89% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, Iradimed Corp is reporting a growth rate of -1,694.53%; that's higher than merely 1.2% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Iradimed Corp, a group of peers worth examining would be EVER, RFIL, INGN, SHYF, and KIDS.
  • IRMD's SEC filings can be seen here. And to visit Iradimed Corp's official web site, go to

IRMD Valuation Summary

  • In comparison to the median Healthcare stock, IRMD's price/sales ratio is 3.96% higher, now standing at 11.8.
  • IRMD's price/earnings ratio has moved up 46.9 over the prior 87 months.
  • Over the past 87 months, IRMD's price/earnings ratio has gone up 46.9.

Below are key valuation metrics over time for IRMD.

Stock Date P/S P/B P/E EV/EBIT
IRMD 2021-08-31 11.8 6.4 91.0 71.4
IRMD 2021-08-30 11.7 6.4 90.5 71.0
IRMD 2021-08-27 11.8 6.4 90.9 71.4
IRMD 2021-08-26 11.7 6.4 90.3 70.8
IRMD 2021-08-25 11.6 6.3 89.2 69.8
IRMD 2021-08-24 11.7 6.4 90.4 70.9

IRMD Growth Metrics

    The year over year cash and equivalents growth rate now stands at 13.81%.
  • Its 3 year net income to common stockholders growth rate is now at -12.21%.
  • The year over year net income to common stockholders growth rate now stands at -89.67%.
Over the past 15 months, IRMD's revenue has gone up $7,752,599.

The table below shows IRMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 41.81458 11.25816 9.325471
2021-09-30 38.48776 10.38818 6.070218
2021-06-30 35.27956 8.344037 4.568603
2021-03-31 32.26383 5.563942 0.986639
2020-12-31 31.71737 5.817496 1.369001
2020-09-30 34.06198 7.270287 3.97327

IRMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IRMD has a Quality Grade of A, ranking ahead of 97.83% of graded US stocks.
  • IRMD's asset turnover comes in at 0.488 -- ranking 96th of 186 Medical Equipment stocks.
  • DYNT, NUVA, and ELMD are the stocks whose asset turnover ratios are most correlated with IRMD.

The table below shows IRMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.488 0.753 0.283
2021-03-31 0.457 0.749 0.017
2020-12-31 0.455 0.743 -0.031
2020-09-30 0.497 0.742 0.053
2020-06-30 0.545 0.753 0.144
2020-03-31 0.609 0.768 0.401

IRMD Price Target

For more insight on analysts targets of IRMD, see our IRMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $38.00 Average Broker Recommendation 1.25 (Strong Buy)

IRMD Stock Price Chart Interactive Chart >

Price chart for IRMD

IRMD Price/Volume Stats

Current price $35.54 52-week high $55.92
Prev. close $36.12 52-week low $28.90
Day low $34.97 Volume 26,114
Day high $36.40 Avg. volume 65,745
50-day MA $35.64 Dividend yield N/A
200-day MA $40.72 Market Cap 446.56M

iRadimed Corporation (IRMD) Company Bio

IRadimed Corporation manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible products in the United States and internationally. The company was founded in 1992 and is based in Winter Springs, Florida.

IRMD Latest News Stream

Event/Time News Detail
Loading, please wait...

IRMD Latest Social Stream

Loading social stream, please wait...

View Full IRMD Social Stream

Latest IRMD News From Around the Web

Below are the latest news stories about Iradimed Corp that investors may wish to consider to help them evaluate IRMD as an investment opportunity.

iRadimed (IRMD) is an Incredible Growth Stock: 3 Reasons Why

iRadimed (IRMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Yahoo | February 23, 2022

Is iRadimed (IRMD) Outperforming Other Medical Stocks This Year?

Here is how iRadimed (IRMD) and AllScripts Healthcare (MDRX) have performed compared to their sector so far this year.

Yahoo | February 15, 2022

Recent Price Trend in iRadimed (IRMD) is Your Friend, Here's Why

iRadimed (IRMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Yahoo | February 14, 2022

7 Safe Stocks to Rely On When the Market Swerves

When markets that have flown so high for so long start to tumble, along with an economy that transitioning, safe stocks are essential.

Louis Navellier and the InvestorPlace Research Staff on InvestorPlace | February 9, 2022

IRadimed Corporation declares $1.00 special dividend

IRadimed Corporation (NASDAQ:IRMD) declares $1.00/share special dividend.Payable Feb. 24; for shareholders of record Feb. 17; ex-div Feb.

Seeking Alpha | February 7, 2022

Read More 'IRMD' Stories Here

IRMD Price Returns

1-mo -6.45%
3-mo 12.33%
6-mo -24.86%
1-year 4.38%
3-year 72.27%
5-year 253.63%
YTD -23.09%
2021 102.68%
2020 -2.48%
2019 -4.42%
2018 61.45%
2017 36.49%

Continue Researching IRMD

Want to see what other sources are saying about Iradimed Corp's financials and stock price? Try the links below:

Iradimed Corp (IRMD) Stock Price | Nasdaq
Iradimed Corp (IRMD) Stock Quote, History and News - Yahoo Finance
Iradimed Corp (IRMD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6635 seconds.